お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、過免疫グロブリンの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に過免疫グロブリン市場を分類しています。
本レポートでは世界の過免疫グロブリン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：CSL Behring、Grifols、Biotest、Kedrion、CBPO、Emergent (Cangene)、Kamada、CNBG、Hualan Bio、Shanghai RAAS、Sichuan Yuanda Shuyang、ADMA Biologics

レポートは過免疫グロブリンの主要生産者を調査し、主要地域や国の消費状況も提供します。過免疫グロブリンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Hepatitis B Immunoglobulins
    Rabies Immunoglobulins
    Tetanus Immunoglobulins
    Rho(D) Immunoglobulins
    Herpes Zoster Immune Globulin
    Other

用途別の市場セグメント：
    Government Institutions
    Private Sector
    Other

本レポートの詳細内容
本レポートは、世界の過免疫グロブリン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて過免疫グロブリン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の過免疫グロブリン生産量、成長率、市場シェアを調査している。

二. 消費面では、過免疫グロブリンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの過免疫グロブリン売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の過免疫グロブリン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本過免疫グロブリンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：過免疫グロブリンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 過免疫グロブリンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける過免疫グロブリンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章過免疫グロブリンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：過免疫グロブリンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：過免疫グロブリンの主要メーカーの概要を提供し、製品の説明と仕様、過免疫グロブリンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：過免疫グロブリンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously. Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The global Hyperimmune Globulins market is projected to grow from US$ 1936 million in 2024 to US$ 2906 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%. Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.  In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
The hyperimmune globulin market is primarily driven by the increasing prevalence of infectious diseases and the rising demand for immunoglobulin therapies. These therapies are crucial in treating immunodeficiency disorders and providing passive immunity against various pathogens, which fuels market growth. Additionally, advancements in plasma-derived therapies and increasing government initiatives for immunization programs contribute to market expansion.
However, the market faces significant challenges, such as the high cost of treatment and limited availability of plasma, which is a critical raw material for hyperimmune globulin production. Moreover, stringent regulatory requirements for product approval and potential side effects associated with immunoglobulin therapies can hinder market growth.
Report Includes
This report presents an overview of global market for Hyperimmune Globulins, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hyperimmune Globulins, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Hyperimmune Globulins, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hyperimmune Globulins sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hyperimmune Globulins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hyperimmune Globulins sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, etc.

Market Segmentation
By Company
    CSL Behring
    Grifols
    Biotest
    Kedrion
    CBPO
    Emergent (Cangene)
    Kamada
    CNBG
    Hualan Bio
    Shanghai RAAS
    Sichuan Yuanda Shuyang
    ADMA Biologics

Segment by Type
    Hepatitis B Immunoglobulins
    Rabies Immunoglobulins
    Tetanus Immunoglobulins
    Rho(D) Immunoglobulins
    Herpes Zoster Immune Globulin
    Other

Segment by Application
    Government Institutions
    Private Sector
    Other

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hyperimmune Globulins in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hyperimmune Globulins sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Hyperimmune Globulins Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of Hepatitis B Immunoglobulins
 Table 3. Major Manufacturers of Rabies Immunoglobulins
 Table 4. Major Manufacturers of Tetanus Immunoglobulins
 Table 5. Major Manufacturers of Rho(D) Immunoglobulins
 Table 6. Major Manufacturers of Herpes Zoster Immune Globulin
 Table 7. Major Manufacturers of Other
 Table 8. Global Hyperimmune Globulins Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. Global Hyperimmune Globulins Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Hyperimmune Globulins Revenue by Region (2019-2024) & (US$ Million)
 Table 11. Global Hyperimmune Globulins Revenue by Region (2025-2030) & (US$ Million)
 Table 12. Global Hyperimmune Globulins Revenue Market Share by Region (2019-2024)
 Table 13. Global Hyperimmune Globulins Revenue Market Share by Region (2025-2030)
 Table 14. Global Hyperimmune Globulins Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 15. Global Hyperimmune Globulins Sales by Region (2019-2024) & (K Units)
 Table 16. Global Hyperimmune Globulins Sales by Region (2025-2030) & (K Units)
 Table 17. Global Hyperimmune Globulins Sales Market Share by Region (2019-2024)
 Table 18. Global Hyperimmune Globulins Sales Market Share by Region (2025-2030)
 Table 19. Global Hyperimmune Globulins Sales by Manufacturers (2019-2024) & (K Units)
 Table 20. Global Hyperimmune Globulins Sales Share by Manufacturers (2019-2024)
 Table 21. Global Hyperimmune Globulins Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 22. Global Hyperimmune Globulins Revenue Market Share by Manufacturers (2019-2024)
 Table 23. Global Key Players of Hyperimmune Globulins, Industry Ranking, 2021 VS 2022 VS 2023
 Table 24. Hyperimmune Globulins Price by Manufacturers (2019-2024) & (USD/Unit)
 Table 25. Global Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 26. Global Hyperimmune Globulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2023)
 Table 27. Global Key Manufacturers of Hyperimmune Globulins, Manufacturing Base Distribution and Headquarters
 Table 28. Global Key Manufacturers of Hyperimmune Globulins, Product Offered and Application
 Table 29. Global Key Manufacturers of Hyperimmune Globulins, Date of Enter into This Industry
 Table 30. Mergers & Acquisitions, Expansion Plans
 Table 31. Global Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)
 Table 32. Global Hyperimmune Globulins Sales by Type (2025-2030) & (K Units)
 Table 33. Global Hyperimmune Globulins Sales Share by Type (2019-2024)
 Table 34. Global Hyperimmune Globulins Sales Share by Type (2025-2030)
 Table 35. Global Hyperimmune Globulins Revenue by Type (2019-2024) & (US$ Million)
 Table 36. Global Hyperimmune Globulins Revenue by Type (2025-2030) & (US$ Million)
 Table 37. Global Hyperimmune Globulins Revenue Share by Type (2019-2024)
 Table 38. Global Hyperimmune Globulins Revenue Share by Type (2025-2030)
 Table 39. Hyperimmune Globulins Price by Type (2019-2024) & (USD/Unit)
 Table 40. Global Hyperimmune Globulins Price Forecast by Type (2025-2030) & (USD/Unit)
 Table 41. Global Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)
 Table 42. Global Hyperimmune Globulins Sales by Application (2025-2030) & (K Units)
 Table 43. Global Hyperimmune Globulins Sales Share by Application (2019-2024)
 Table 44. Global Hyperimmune Globulins Sales Share by Application (2025-2030)
 Table 45. Global Hyperimmune Globulins Revenue by Application (2019-2024) & (US$ Million)
 Table 46. Global Hyperimmune Globulins Revenue by Application (2025-2030) & (US$ Million)
 Table 47. Global Hyperimmune Globulins Revenue Share by Application (2019-2024)
 Table 48. Global Hyperimmune Globulins Revenue Share by Application (2025-2030)
 Table 49. Hyperimmune Globulins Price by Application (2019-2024) & (USD/Unit)
 Table 50. Global Hyperimmune Globulins Price Forecast by Application (2025-2030) & (USD/Unit)
 Table 51. US & Canada Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)
 Table 52. US & Canada Hyperimmune Globulins Sales by Type (2025-2030) & (K Units)
 Table 53. US & Canada Hyperimmune Globulins Revenue by Type (2019-2024) & (US$ Million)
 Table 54. US & Canada Hyperimmune Globulins Revenue by Type (2025-2030) & (US$ Million)
 Table 55. US & Canada Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)
 Table 56. US & Canada Hyperimmune Globulins Sales by Application (2025-2030) & (K Units)
 Table 57. US & Canada Hyperimmune Globulins Revenue by Application (2019-2024) & (US$ Million)
 Table 58. US & Canada Hyperimmune Globulins Revenue by Application (2025-2030) & (US$ Million)
 Table 59. US & Canada Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 60. US & Canada Hyperimmune Globulins Revenue by Country (2019-2024) & (US$ Million)
 Table 61. US & Canada Hyperimmune Globulins Revenue by Country (2025-2030) & (US$ Million)
 Table 62. US & Canada Hyperimmune Globulins Sales by Country (2019-2024) & (K Units)
 Table 63. US & Canada Hyperimmune Globulins Sales by Country (2025-2030) & (K Units)
 Table 64. Europe Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)
 Table 65. Europe Hyperimmune Globulins Sales by Type (2025-2030) & (K Units)
 Table 66. Europe Hyperimmune Globulins Revenue by Type (2019-2024) & (US$ Million)
 Table 67. Europe Hyperimmune Globulins Revenue by Type (2025-2030) & (US$ Million)
 Table 68. Europe Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)
 Table 69. Europe Hyperimmune Globulins Sales by Application (2025-2030) & (K Units)
 Table 70. Europe Hyperimmune Globulins Revenue by Application (2019-2024) & (US$ Million)
 Table 71. Europe Hyperimmune Globulins Revenue by Application (2025-2030) & (US$ Million)
 Table 72. Europe Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 73. Europe Hyperimmune Globulins Revenue by Country (2019-2024) & (US$ Million)
 Table 74. Europe Hyperimmune Globulins Revenue by Country (2025-2030) & (US$ Million)
 Table 75. Europe Hyperimmune Globulins Sales by Country (2019-2024) & (K Units)
 Table 76. Europe Hyperimmune Globulins Sales by Country (2025-2030) & (K Units)
 Table 77. China Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)
 Table 78. China Hyperimmune Globulins Sales by Type (2025-2030) & (K Units)
 Table 79. China Hyperimmune Globulins Revenue by Type (2019-2024) & (US$ Million)
 Table 80. China Hyperimmune Globulins Revenue by Type (2025-2030) & (US$ Million)
 Table 81. China Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)
 Table 82. China Hyperimmune Globulins Sales by Application (2025-2030) & (K Units)
 Table 83. China Hyperimmune Globulins Revenue by Application (2019-2024) & (US$ Million)
 Table 84. China Hyperimmune Globulins Revenue by Application (2025-2030) & (US$ Million)
 Table 85. Asia Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)
 Table 86. Asia Hyperimmune Globulins Sales by Type (2025-2030) & (K Units)
 Table 87. Asia Hyperimmune Globulins Revenue by Type (2019-2024) & (US$ Million)
 Table 88. Asia Hyperimmune Globulins Revenue by Type (2025-2030) & (US$ Million)
 Table 89. Asia Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)
 Table 90. Asia Hyperimmune Globulins Sales by Application (2025-2030) & (K Units)
 Table 91. Asia Hyperimmune Globulins Revenue by Application (2019-2024) & (US$ Million)
 Table 92. Asia Hyperimmune Globulins Revenue by Application (2025-2030) & (US$ Million)
 Table 93. Asia Hyperimmune Globulins Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 94. Asia Hyperimmune Globulins Revenue by Region (2019-2024) & (US$ Million)
 Table 95. Asia Hyperimmune Globulins Revenue by Region (2025-2030) & (US$ Million)
 Table 96. Asia Hyperimmune Globulins Sales by Region (2019-2024) & (K Units)
 Table 97. Asia Hyperimmune Globulins Sales by Region (2025-2030) & (K Units)
 Table 98. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)
 Table 99. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Type (2025-2030) & (K Units)
 Table 100. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Type (2019-2024) & (US$ Million)
 Table 101. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Type (2025-2030) & (US$ Million)
 Table 102. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)
 Table 103. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Application (2025-2030) & (K Units)
 Table 104. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Application (2019-2024) & (US$ Million)
 Table 105. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Application (2025-2030) & (US$ Million)
 Table 106. Middle East, Africa and Latin America Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 107. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Country (2019-2024) & (US$ Million)
 Table 108. Middle East, Africa and Latin America Hyperimmune Globulins Revenue by Country (2025-2030) & (US$ Million)
 Table 109. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Country (2019-2024) & (K Units)
 Table 110. Middle East, Africa and Latin America Hyperimmune Globulins Sales by Country (2025-2030) & (K Units)
 Table 111. CSL Behring Company Information
 Table 112. CSL Behring Description and Major Businesses
 Table 113. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 114. CSL Behring Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 115. CSL Behring Recent Developments
 Table 116. Grifols Company Information
 Table 117. Grifols Description and Major Businesses
 Table 118. Grifols Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 119. Grifols Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 120. Grifols Recent Developments
 Table 121. Biotest Company Information
 Table 122. Biotest Description and Major Businesses
 Table 123. Biotest Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 124. Biotest Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 125. Biotest Recent Developments
 Table 126. Kedrion Company Information
 Table 127. Kedrion Description and Major Businesses
 Table 128. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 129. Kedrion Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 130. Kedrion Recent Developments
 Table 131. CBPO Company Information
 Table 132. CBPO Description and Major Businesses
 Table 133. CBPO Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 134. CBPO Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 135. CBPO Recent Developments
 Table 136. Emergent (Cangene) Company Information
 Table 137. Emergent (Cangene) Description and Major Businesses
 Table 138. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 139. Emergent (Cangene) Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 140. Emergent (Cangene) Recent Developments
 Table 141. Kamada Company Information
 Table 142. Kamada Description and Major Businesses
 Table 143. Kamada Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 144. Kamada Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 145. Kamada Recent Developments
 Table 146. CNBG Company Information
 Table 147. CNBG Description and Major Businesses
 Table 148. CNBG Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 149. CNBG Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 150. CNBG Recent Developments
 Table 151. Hualan Bio Company Information
 Table 152. Hualan Bio Description and Major Businesses
 Table 153. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 154. Hualan Bio Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 155. Hualan Bio Recent Developments
 Table 156. Shanghai RAAS Company Information
 Table 157. Shanghai RAAS Description and Major Businesses
 Table 158. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 159. Shanghai RAAS Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 160. Shanghai RAAS Recent Developments
 Table 161. Sichuan Yuanda Shuyang Company Information
 Table 162. Sichuan Yuanda Shuyang Description and Major Businesses
 Table 163. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 164. Sichuan Yuanda Shuyang Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 165. Sichuan Yuanda Shuyang Recent Developments
 Table 166. ADMA Biologics Company Information
 Table 167. ADMA Biologics Description and Major Businesses
 Table 168. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
 Table 169. ADMA Biologics Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
 Table 170. ADMA Biologics Recent Developments
 Table 171. Key Raw Materials Lists
 Table 172. Raw Materials Key Suppliers Lists
 Table 173. Hyperimmune Globulins Distributors List
 Table 174. Hyperimmune Globulins Customers List
 Table 175. Hyperimmune Globulins Market Trends
 Table 176. Hyperimmune Globulins Market Drivers
 Table 177. Hyperimmune Globulins Market Challenges
 Table 178. Hyperimmune Globulins Market Restraints
 Table 179. Research Programs/Design for This Report
 Table 180. Key Data Information from Secondary Sources
 Table 181. Key Data Information from Primary Sources


List of Figures
 Figure 1. Hyperimmune Globulins Product Picture
 Figure 2. Global Hyperimmune Globulins Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Hyperimmune Globulins Market Share by Type: 2023 & 2030
 Figure 4. Hepatitis B Immunoglobulins Product Picture
 Figure 5. Rabies Immunoglobulins Product Picture
 Figure 6. Tetanus Immunoglobulins Product Picture
 Figure 7. Rho(D) Immunoglobulins Product Picture
 Figure 8. Herpes Zoster Immune Globulin Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Hyperimmune Globulins Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 11. Global Hyperimmune Globulins Market Share by Application: 2023 & 2030
 Figure 12. Government Institutions
 Figure 13. Private Sector
 Figure 14. Other
 Figure 15. Hyperimmune Globulins Report Years Considered
 Figure 16. Global Hyperimmune Globulins Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 18. Global Hyperimmune Globulins Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 19. Global Hyperimmune Globulins Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 20. Global Hyperimmune Globulins Revenue Market Share by Region (2019-2030)
 Figure 21. Global Hyperimmune Globulins Sales (2019-2030) & (K Units)
 Figure 22. Global Hyperimmune Globulins Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 23. Global Hyperimmune Globulins Sales Market Share by Region (2019-2030)
 Figure 24. US & Canada Hyperimmune Globulins Sales YoY (2019-2030) & (K Units)
 Figure 25. US & Canada Hyperimmune Globulins Revenue YoY (2019-2030) & (US$ Million)
 Figure 26. Europe Hyperimmune Globulins Sales YoY (2019-2030) & (K Units)
 Figure 27. Europe Hyperimmune Globulins Revenue YoY (2019-2030) & (US$ Million)
 Figure 28. China Hyperimmune Globulins Sales YoY (2019-2030) & (K Units)
 Figure 29. China Hyperimmune Globulins Revenue YoY (2019-2030) & (US$ Million)
 Figure 30. Asia (excluding China) Hyperimmune Globulins Sales YoY (2019-2030) & (K Units)
 Figure 31. Asia (excluding China) Hyperimmune Globulins Revenue YoY (2019-2030) & (US$ Million)
 Figure 32. Middle East, Africa and Latin America Hyperimmune Globulins Sales YoY (2019-2030) & (K Units)
 Figure 33. Middle East, Africa and Latin America Hyperimmune Globulins Revenue YoY (2019-2030) & (US$ Million)
 Figure 34. Global Hyperimmune Globulins Sales Share by Manufacturers (2023)
 Figure 35. The Hyperimmune Globulins Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 36. Global Hyperimmune Globulins Revenue Share by Manufacturers (2023)
 Figure 37. The Top 5 and 10 Largest Manufacturers of Hyperimmune Globulins in the World: Market Share by Hyperimmune Globulins Revenue in 2023
 Figure 38. Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 39. Global Hyperimmune Globulins Sales Market Share by Type (2019-2030)
 Figure 40. Global Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
 Figure 41. Global Hyperimmune Globulins Sales Market Share by Application (2019-2030)
 Figure 42. Global Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
 Figure 43. US & Canada Hyperimmune Globulins Sales Market Share by Type (2019-2030)
 Figure 44. US & Canada Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
 Figure 45. US & Canada Hyperimmune Globulins Sales Market Share by Application (2019-2030)
 Figure 46. US & Canada Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
 Figure 47. US & Canada Hyperimmune Globulins Revenue Share by Country (2019-2030)
 Figure 48. US & Canada Hyperimmune Globulins Sales Share by Country (2019-2030)
 Figure 49. US Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 50. Canada Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 51. Europe Hyperimmune Globulins Sales Market Share by Type (2019-2030)
 Figure 52. Europe Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
 Figure 53. Europe Hyperimmune Globulins Sales Market Share by Application (2019-2030)
 Figure 54. Europe Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
 Figure 55. Europe Hyperimmune Globulins Revenue Share by Country (2019-2030)
 Figure 56. Europe Hyperimmune Globulins Sales Share by Country (2019-2030)
 Figure 57. Germany Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 58. France Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 59. U.K. Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 60. Italy Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 61. Russia Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 62. China Hyperimmune Globulins Sales Market Share by Type (2019-2030)
 Figure 63. China Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
 Figure 64. China Hyperimmune Globulins Sales Market Share by Application (2019-2030)
 Figure 65. China Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
 Figure 66. Asia Hyperimmune Globulins Sales Market Share by Type (2019-2030)
 Figure 67. Asia Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
 Figure 68. Asia Hyperimmune Globulins Sales Market Share by Application (2019-2030)
 Figure 69. Asia Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
 Figure 70. Asia Hyperimmune Globulins Revenue Share by Region (2019-2030)
 Figure 71. Asia Hyperimmune Globulins Sales Share by Region (2019-2030)
 Figure 72. Japan Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 73. South Korea Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 74. China Taiwan Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 75. Southeast Asia Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 76. India Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 77. Australia Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 78. Middle East, Africa and Latin America Hyperimmune Globulins Sales Market Share by Type (2019-2030)
 Figure 79. Middle East, Africa and Latin America Hyperimmune Globulins Revenue Market Share by Type (2019-2030)
 Figure 80. Middle East, Africa and Latin America Hyperimmune Globulins Sales Market Share by Application (2019-2030)
 Figure 81. Middle East, Africa and Latin America Hyperimmune Globulins Revenue Market Share by Application (2019-2030)
 Figure 82. Middle East, Africa and Latin America Hyperimmune Globulins Revenue Share by Country (2019-2030)
 Figure 83. Middle East, Africa and Latin America Hyperimmune Globulins Sales Share by Country (2019-2030)
 Figure 84. Brazil Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 85. Mexico Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 86. Turkey Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 87. Israel Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 88. GCC Countries Hyperimmune Globulins Revenue (2019-2030) & (US$ Million)
 Figure 89. Hyperimmune Globulins Value Chain
 Figure 90. Hyperimmune Globulins Production Process
 Figure 91. Channels of Distribution (Direct Vs Distribution)
 Figure 92. Bottom-up and Top-down Approaches for This Report
 Figure 93. Data Triangulation
 Figure 94. Key Executives Interviewed